首页> 外文期刊>Oncology Research >Oncogenic Role of MicroRNA-30b-5p in Glioblastoma Through Targeting Proline-Rich Transmembrane Protein 2
【24h】

Oncogenic Role of MicroRNA-30b-5p in Glioblastoma Through Targeting Proline-Rich Transmembrane Protein 2

机译:MicroRNA-30B-5P在胶质母细胞瘤中的致癌作用通过靶向富含脯氨酸的跨膜蛋白2

获取原文
获取原文并翻译 | 示例
       

摘要

MicroRNAs (miRs) have been found to play promoting or suppressive roles in different human cancers. However, the exact regulatory mechanism of miR-30b in glioblastoma remains unknown. Here we have shown that the expression of miR-30b is significantly increased in glioblastoma tissues and cell lines. Moreover, a high expression of miR-30b is significantly associated with a shorter survival time for glioblastoma patients. Knockdown of miR-30b caused a significant reduction in the proliferation, migration, and invasion of U87 and A172 cells. Proline-rich transmembrane protein 2 (PRRT2) was further identified as a novel target gene of miR-30b. and its protein expression is negatively regulated by miR-30b in U87 and A172 cells. Furthermore, PRRT2 is significantly downregulated in glioblastoma tissues and cell lines, and we found an inverse correlation between miR-30b and PRRT2 expression in glioblastoma tissues. In addition, inhibition of PRRT2 reversed the suppressive effect of miR-30b downregulation on the malignant phenotypes of U87 and A172 cells. Accordingly, we demonstrated that miR-30b promotes glioblastoma cell proliferation, migration, and invasion via targeting PRRT2. Therefore. miR-30b may be used as a promising therapeutic target for glioblastoma.
机译:已经发现MicroRNA(MIRS)在不同人类癌症中发挥促进或抑制作用。然而,miR-30b在胶质母细胞瘤中的确切调节机制仍然未知。在这里,我们已经表明MiR-30B的表达在胶质母细胞瘤组织和细胞系中显着增加。此外,miR-30b的高表达与胶质母细胞瘤患者的较短存活时间显着相关。 miR-30b的敲低导致U87和A172细胞的增殖,迁移和侵袭显着降低。富含富集的跨膜蛋白2(PRRT2)进一步鉴定为miR-30b的新靶基因。其蛋白质表达由U87和A172细胞中的miR-30b负调节。此外,PRRT2在胶质母细胞瘤组织和细胞系中显着下调,我们发现MIR-30B和PRRT2在胶质母细胞瘤组织中的逆相关性。此外,PRRT2的抑制反转了MIR-30B下调对U87和A172细胞恶性表型的抑制作用。因此,我们证明MIR-30B通过靶向PRRT2促进胶质母细胞瘤细胞增殖,迁移和侵袭。所以。 miR-30b可以用作胶质母细胞瘤的有希望的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号